Ana Salazar Modela Tu Cuerpo has issued a nationwide voluntary recall of Lipofit Extreme Fat Burner 2.0 after testing by the U.S. Food and Drug Administration detected two undeclared substances in the product. The daytime tablets contained fluoxetine, while the nighttime tablets contained 2,4-dinitrophenol, commonly known as DNP. The product was marketed as a weight-loss dietary supplement, but products containing these substances cannot legally be marketed as dietary supplements. The recall covers lot 25M12F, which has an expiration date of September 2027. The product was sold directly to consumers in the United States through online channels. The company said it had stopped selling and promoting the product and had quarantined its remaining inventory. No known adverse events associated with the recalled product had been reported to the company as of the announcement date. Consumers should stop using the affected product immediately. Keep it away from children and others, and do not sell, give away, or transfer it. Purchasers should contact the company for return or disposal instructions and should not mail or discard the product until those instructions are provided. Anyone experiencing a health problem that may be associated with the product should contact a physician or other healthcare professional. Adverse reactions and product-quality concerns may also be reported through the FDA MedWatch program. The FDA-posted notice warns that exposure may be associated with serious or life-threatening effects, including nausea, vomiting, sweating, dizziness, headache, abnormal heart rhythms, rapid heart rate, cardiac arrest, seizures, abnormal bleeding, suicidal thoughts, dangerously high body temperature, rapid breathing, and possible sudden death. Long-term exposure may damage the eyes, skin, bone marrow, nervous system, and heart. Certain medication combinations may further increase the risk of fatal cardiac events.